114209-49-3

Basic information

• Product Name: 4-Chloro-6-(4-morpholinyl)-1,3,5-triazin-2-ylamine
• Synonyms: 4-Chloro-6-(4-morpholinyl)-1,3,5-triazin-2-ylamine
• CAS NO: 114209-49-3
• Molecular Formula: C₇H₁₀ClN₅O
• Molecular Weight: 215.6402
• Mol File: 114209-49-3.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Chloro-6-(4-morpholinyl)-1,3,5-triazin-2-ylamine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloro-6-(4-morpholinyl)-1,3,5-triazin-2-ylamine(114209-49-3)
• EPA Substance Registry System: 4-Chloro-6-(4-morpholinyl)-1,3,5-triazin-2-ylamine(114209-49-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 114209-49-3(Hazardous Substances Data)

Upstream product

• 110-91-8 morpholine 
• 933-20-0 4,6-dichloro-1,3,5-triazin-2-amine 
• 108-77-0 1,3,5-trichloro-2,4,6-triazine 

Downstream Products

• 1391925-06-6 3-(4-amino-6-morpholino-1,3,5-triazin-2-yl)phenol 

Relevant articles and documents

Hybrid 4-Aminoquinoline-1,3,5-triazine Derivatives: Design, Synthesis, Characterization, and Antibacterial Evaluation

A series of novel 4-aminoquinoline 1,3,5-triazine derivatives were synthesized and characterized by FTIR, 1H-NMR, 13C-NMR, MS, and elemental analysis. The antibacterial activities of synthesized compounds were tested against three Gram-positive bacteria, namely Bacillus subtilis (NCIM-2063), Bacillus cereus (NCIM-2156), and Staphylococcus aureus (NCIM-2079), and four Gram-negative bacteria, namely Proteus vulgaris (NCIM-2027), Proteus mirabilis (NCIM-2241), Escherichia coli (NCIM-2065), and Pseudomonas aeruginosa (NCIM-2036), using ciprofloxacin as reference standard drug. Results showed compound 9a and 9e as potent antibacterial agents against all bacterial strains except Bacillus cereus (NCIM-2156).

BICYCLIC COMPOUND AND USE THEREOF FOR INHIBITING SUV39H2

The present invention directs to a compound represented by formula (I).